Impact of treatment delay in acute myeloid leukemia revisited

Blood Adv. 2021 Feb 9;5(3):787-790. doi: 10.1182/bloodadvances.2020003806.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Mutation
  • Time-to-Treatment*